RMC-6236 trials for Non-small Cell Lung Cancer (NSCLC)

All RMC-6236 trials · All Non-small Cell Lung Cancer (NSCLC) trials

Phase breakdown

Recruiting trials studying RMC-6236 for Non-small Cell Lung Cancer (NSCLC)

• Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
  NCT06162221 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 93 locations
• Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
  NCT05379985 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
  NCT06040541 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations

Common questions

How many trials study RMC-6236 for Non-small Cell Lung Cancer (NSCLC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.